Find Pipamperone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Floropipamide, 1893-33-0, Dipiperon, Dipiperone, Dipiperal, Piperonyl
Molecular Formula
C21H30FN3O2
Molecular Weight
375.5  g/mol
InChI Key
AXKPFOAXAHJUAG-UHFFFAOYSA-N
FDA UNII
5402501F0W

Pipamperone
Pipamperone is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia. It was developed by Janssen Pharmaceutica in 1961 and started its first round of clinical trials in 1963. In an effort to improve [haloperidol]'s pharmacological effects, Janssen discovered that pipamperone, an agent whose pharmacological profile was distinct from haloperidol and all other known antipsychotic drugs at this time, had significant anti-tryptamine activity. Some studies suggest pipamperone was the first atypical antipsychotic. Interestingly, when [risperidone] was created, Janssen suggested it was a more potent version of pipamperone. Synthesized in the year 1984, risperidones pharmacological properties were similar to pipamperones in that both block more serotonin more potently than dopamine.
1 2D Structure

Pipamperone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidin-1-ylpiperidine-4-carboxamide
2.1.2 InChI
InChI=1S/C21H30FN3O2/c22-18-8-6-17(7-9-18)19(26)5-4-12-24-15-10-21(11-16-24,20(23)27)25-13-2-1-3-14-25/h6-9H,1-5,10-16H2,(H2,23,27)
2.1.3 InChI Key
AXKPFOAXAHJUAG-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CCN(CC1)C2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)C(=O)N
2.2 Other Identifiers
2.2.1 UNII
5402501F0W
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1'-(3-(4-fluorobenzoyl)propyl)-(1,4'-bipiperidine) -4'-carboxamide

2. Dipiperon

3. Pipamperon-neuraxpharm

4. Pipamperone Dihydrochloride

5. R 3345

2.3.2 Depositor-Supplied Synonyms

1. Floropipamide

2. 1893-33-0

3. Dipiperon

4. Dipiperone

5. Dipiperal

6. Piperonyl

7. Piperonil

8. R 3345

9. Pipamperona

10. Pipamperonum

11. Pipamperone Hydrochloride

12. Mcn-jr-3345

13. Pipaneperone

14. Pipamperone Free Base

15. Pipamperone Dihydrochloride Approx. 99

16. Nsc-759178

17. 1'-(3-(p-fluorobenzoyl)propyl)-(1,4'-bipiperidine)-4'-carboxamide

18. (1,4'-bipiperidine)-4'-carboxamide, 1'-(3-(p-fluorobenzoyl)propyl)-

19. Chebi:78549

20. 1893-33-0 (free Base)

21. 4'-fluoro-4-(4-n-piperidino-4-carbamidopiperidino)butyrophenone

22. P-fluoro-gamma-(4-piperidino-4-carbamoylpiperidino)butyrophenone

23. R-3345

24. Carpiperone

25. Fluoropipamide

26. [1,4'-bipiperidine]-4'-carboxamide, 1'-[4-(4-fluorophenyl)-4-oxobutyl]-

27. 1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidin-1-ylpiperidine-4-carboxamide

28. Floropipamide; Mcn-jr 3345; R 3345

29. 5402501f0w

30. 1'-[4-(4-fluorophenyl)-4-oxobutyl]-1,4'-bipiperidine-4'-carboxamide

31. (1,4'-bipiperidine)-4'-carboxamide, 1'-(4-(4-fluorophenyl)-4-oxobutyl)-

32. Pipamperon

33. 1'-(4-(4-fluorophenyl)-4-oxobutyl)-[1,4'-bipiperidine]-4'-carboxamide

34. Pipamperonum [inn-latin]

35. Pipamperona [inn-spanish]

36. Pipamperone [usan:inn:ban]

37. Ccris 9071

38. Ncgc00165864-02

39. Brn 0496532

40. 1'-(4-(4-fluorophenyl)-4-oxobutyl)-1,4'-bipiperidine-4'-carboxamide

41. 1'-[4-(4-fluorophenyl)-4-oxobutyl]-[1,4'-bipiperidine]-4'-carboxamide

42. Unii-5402501f0w

43. Propitan (salt/mix)

44. Isonipacotamide, 1-(3-(p-fluorobenzoyl)propyl)-4-piperidino-

45. Pipamperone [mi]

46. Pipamperone [inn]

47. Pipamperone (usan/inn)

48. Pipamperone [usan]

49. Gtpl92

50. Schembl2412

51. Pipamperone [mart.]

52. Pipamperone [who-dd]

53. 5-22-13-00536 (beilstein Handbook Reference)

54. Mcn-jr 3345

55. Chembl440294

56. Dtxsid8048369

57. Bdbm81483

58. Hms3264g14

59. Pharmakon1600-01505690

60. Nsc_4830

61. 1'-(3-(p-fluorobenzoyl)propyl)(1,4'-bipiperidine)-4'-carboxamide

62. Mfcd00242979

63. Nsc759178

64. Pdsp1_001560

65. Pdsp2_001544

66. Zinc21297287

67. Ccg-213514

68. Db09286

69. Nsc 759178

70. Ncgc00165864-01

71. Ac-32938

72. Pipamperonedihydrochlorideapprox.99

73. Cas_1893-33-0

74. Sbi-0206899.p001

75. Hy-100703

76. Cs-0020023

77. P2315

78. D02622

79. Ab01563106_01

80. A929272

81. L000727

82. Q415118

83. Sr-05000001930

84. Sr-05000001930-1

85. Brd-k26801045-001-01-1

86. Isonipecotamide, 1-(3-(p-fluorobenzoyl)propyl)-4-piperidino-

87. P-fluoro-.gamma.-(4-piperidino-4-carbamoylpiperidino)butyrophenone

88. 1,4'-bipiperidine)-4'-carboxamide, 1'-(4-(4-fluorophenyl)-4-oxobutyl)-

89. 1-(4-fluorophenyl)-4-(4-piperidino-4-carbamoylpiperidino)-1-butanone

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 375.5 g/mol
Molecular Formula C21H30FN3O2
XLogP32
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass375.23220537 g/mol
Monoisotopic Mass375.23220537 g/mol
Topological Polar Surface Area66.6 Ų
Heavy Atom Count27
Formal Charge0
Complexity506
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of chronic psychoses and states of aggressiveness of various origins.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Pipamperone is an antipsychotic medication that has sedative effects, which may be beneficial in the management of agitation and disordered sleep. Pipamperone, showing antidopaminergic and anti-serotonergic properties, has been noted for its anti- agitation effects and for its ability to normalize sleep rhythms in psychiatric patients. One study showed that pipamperone increased the expression of D4 (dopaminergic) receptors, explaining its helpfulness in decreasing positive psychotic symptoms, such as delusions and hallucinations.


5.2 MeSH Pharmacological Classification

Antipsychotic Agents

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)


Serotonin Antagonists

Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)


5.3 ATC Code

N05AD05

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


N - Nervous system

N05 - Psycholeptics

N05A - Antipsychotics

N05AD - Butyrophenone derivatives

N05AD05 - Pipamperone


5.4 Absorption, Distribution and Excretion

Route of Elimination

Mainly via the kidneys


5.5 Metabolism/Metabolites

Pipamperone is metabolised in the liver.


5.6 Biological Half-Life

17-26h


5.7 Mechanism of Action

Pipamperone binds mainly to 5-HT2A receptors, with a nearly equal affinity to D4 receptors and a moderate affinity for 5-HT2C, D2, D3, 1- and 2B-adrenoceptors. This drug is a selective 5-HT2A, D1 and D4 antagonist. Extrapyramidal adverse effects also appear to be limited in pipamperone treatment compared to traditional antipsychotic medications due to its high receptor selectivity. Pipamperone has a 15-fold higher affinity for D4 than D2 receptors. It has been suggested that D4 receptors may play a role in the modulation of GABAergic neuronal activity by dopamine.


Global Sales Information

Do you need Business Intel? Ask us

ABOUT THIS PAGE

Pipamperone Manufacturers

A Pipamperone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pipamperone, including repackagers and relabelers. The FDA regulates Pipamperone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pipamperone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Pipamperone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Pipamperone Suppliers

A Pipamperone supplier is an individual or a company that provides Pipamperone active pharmaceutical ingredient (API) or Pipamperone finished formulations upon request. The Pipamperone suppliers may include Pipamperone API manufacturers, exporters, distributors and traders.

click here to find a list of Pipamperone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Pipamperone USDMF

A Pipamperone DMF (Drug Master File) is a document detailing the whole manufacturing process of Pipamperone active pharmaceutical ingredient (API) in detail. Different forms of Pipamperone DMFs exist exist since differing nations have different regulations, such as Pipamperone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Pipamperone DMF submitted to regulatory agencies in the US is known as a USDMF. Pipamperone USDMF includes data on Pipamperone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pipamperone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Pipamperone suppliers with USDMF on PharmaCompass.

Pipamperone JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Pipamperone Drug Master File in Japan (Pipamperone JDMF) empowers Pipamperone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Pipamperone JDMF during the approval evaluation for pharmaceutical products. At the time of Pipamperone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Pipamperone suppliers with JDMF on PharmaCompass.

Pipamperone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pipamperone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Pipamperone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Pipamperone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Pipamperone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pipamperone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Pipamperone suppliers with NDC on PharmaCompass.

Pipamperone GMP

Pipamperone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Pipamperone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pipamperone GMP manufacturer or Pipamperone GMP API supplier for your needs.

Pipamperone CoA

A Pipamperone CoA (Certificate of Analysis) is a formal document that attests to Pipamperone's compliance with Pipamperone specifications and serves as a tool for batch-level quality control.

Pipamperone CoA mostly includes findings from lab analyses of a specific batch. For each Pipamperone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Pipamperone may be tested according to a variety of international standards, such as European Pharmacopoeia (Pipamperone EP), Pipamperone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pipamperone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty